Na Inhibitor Testing
Na Inhibitor Testing - Related Videos
01:52
Eukaryotic Transcription Inhibitors
0 Views •
2020
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells. Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
10:33
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
0 Views •
Cited by 4 •
2015
We describe implementation of the REPLACE strategy for targeting protein-protein interactions. REPLACE is an iterative strategy involving synthetic and computational approaches for the conversion of optimized peptidic inhibitors into drug like molecules.
04:00
Modelling Intratumoral Treatment with miRNA Inhibitors: A Method to Analyze the Effect of miRNA Inhibitors on Tumor Growth in Murine Model
0 Views •
2023
This video demonstrates the in vivo delivery of miRNA inhibitors as therapeutic agents against tumor growth in orthotopic mouse models. The intratumoral administration of synthetic miRNA inhibitors or antagomiRs allows them to bind and inhibit endogenous miRNAs, thereby causing mRNA upregulation and suppression of tumor growth.
02:08
Assessing Bacterial Swarming Using a Gradient Inhibitor Plate
0 Views •
2025
Source: Guo, S., et al. Quantifying Bacterial Surface Swarming Motility on Inducer Gradient Plates. J. Vis. Exp. (2022).This video demonstrates the use of a double-layer gradient swarm plate to study bacterial swarming behavior under varying inhibitor concentrations. A plate with a gradient-forming inhibitor in the bottom layer is inoculated with bacteria and incubated. Images are captured at regular intervals to analyze the effect of inhibitor concentration on bacterial swarming.
07:47
Anxiety Testing
0 Views •
2023
Anxiety is a commonly observed behavioral disorder that stems from fear. It is described as increased restlessness, or unpleasant feelings of fear over anticipated events. Experimenters often use rodent models to better understand anxiety disorders in humans. They use different paradigms, like exposing rodents to bright spaces or loud sounds, which are known to induce fear. These tests combined with other interventions such as surgery or drug-administration may assist researchers in pinpointing...
FAQs
A biochemical assay compares neuraminidase activity in the presence of a candidate compound with activity in an untreated control. The enzyme is incubated with a substrate containing sialic acid, and reduced activity indicates that the compound interferes with neuraminidase function. This comparison provides a direct basis for evaluating how strongly different compounds suppress the target enzyme.
The substrate supplies the molecular target on which neuraminidase normally acts. Measuring activity with this substrate allows investigators to detect how much enzymatic function remains after adding a candidate inhibitor. Because the readout is tied to substrate processing, the assay can distinguish reduced enzyme activity from the untreated reference condition and support quantitative comparisons among compounds.
Biochemical testing focuses on the direct effect of a compound on neuraminidase activity under controlled assay conditions. Cell-based testing extends the analysis by examining effects on influenza viral replication or release. Using both formats can connect target-level inhibition with a broader antiviral outcome, helping determine whether reduced enzyme activity corresponds to reduced viral production in cells.
Reduced neuraminidase activity in the presence of a compound supports inhibitor potency against the tested enzyme. In contrast, reduced drug sensitivity indicates that the virus or viral neuraminidase responds less effectively to the inhibitor. Comparing these outcomes across candidates or viral samples helps identify changes relevant to antiviral performance and possible resistance research.
A typical workflow brings together neuraminidase, a candidate inhibitor, and a sialic acid-containing substrate. The components are incubated, enzymatic activity is measured, and the result is compared with an untreated control. Repeating this comparison across candidate compounds or tested conditions produces data that can be used to evaluate and compare inhibitory effects.
Cell-based assays are added when investigators need information beyond direct enzyme inhibition. They can assess whether a candidate affects influenza viral replication or the release of newly formed virions. This application connects biochemical findings with infection-related behavior and helps evaluate whether an inhibitor's effect on neuraminidase is reflected in a broader antiviral response.
Testing provides measurements that help compare antiviral candidates and identify reduced drug sensitivity. In surveillance, these results can support monitoring of influenza samples for changes affecting inhibitor response. During therapeutic development, potency comparisons help prioritize compounds for further study, while the same data contribute to research on how viral resistance may influence treatment performance.